PT3687994T - Agentes de contraste à base de pcta que suportam gadolínio - Google Patents

Agentes de contraste à base de pcta que suportam gadolínio

Info

Publication number
PT3687994T
PT3687994T PT197532963T PT19753296T PT3687994T PT 3687994 T PT3687994 T PT 3687994T PT 197532963 T PT197532963 T PT 197532963T PT 19753296 T PT19753296 T PT 19753296T PT 3687994 T PT3687994 T PT 3687994T
Authority
PT
Portugal
Prior art keywords
pcta
gadolinium
bearing
contrast agents
based contrast
Prior art date
Application number
PT197532963T
Other languages
English (en)
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=63165233&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3687994(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Publication of PT3687994T publication Critical patent/PT3687994T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A61K49/108Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA the metal complex being Gd-DOTA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT197532963T 2018-08-06 2019-08-06 Agentes de contraste à base de pcta que suportam gadolínio PT3687994T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18187422 2018-08-06

Publications (1)

Publication Number Publication Date
PT3687994T true PT3687994T (pt) 2020-12-07

Family

ID=63165233

Family Applications (2)

Application Number Title Priority Date Filing Date
PT197532963T PT3687994T (pt) 2018-08-06 2019-08-06 Agentes de contraste à base de pcta que suportam gadolínio
PT201938248T PT3770160T (pt) 2018-08-06 2019-08-06 Agentes de contraste à base de pcta que suportam gadolínio

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT201938248T PT3770160T (pt) 2018-08-06 2019-08-06 Agentes de contraste à base de pcta que suportam gadolínio

Country Status (14)

Country Link
US (2) US10973934B2 (pt)
EP (3) EP3687994B1 (pt)
JP (1) JP2021533165A (pt)
KR (1) KR20210041566A (pt)
CN (1) CN112533921A (pt)
AU (1) AU2019319599B2 (pt)
BR (1) BR112021001102B1 (pt)
CA (1) CA3105610C (pt)
DK (2) DK3770160T3 (pt)
ES (2) ES2841070T3 (pt)
FI (1) FI3770160T3 (pt)
PL (2) PL3687994T3 (pt)
PT (2) PT3687994T (pt)
WO (1) WO2020030618A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3770160T3 (da) * 2018-08-06 2023-02-20 Bracco Imaging Spa Kontrastmidler baseret på gadolinium-indeholdende pcta
US11370804B2 (en) 2019-01-17 2022-06-28 Guerbet Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
US11426470B2 (en) 2019-01-17 2022-08-30 Guerbet Complex of gadolinium and a chelating ligand derived of a diastereoisomerically enriched PCTA and synthesis method
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
PT4143153T (pt) * 2020-07-16 2023-12-19 Guerbet Sa Método para sintetizar diésteres de ácido 2-bromoglutárico
WO2022013454A1 (fr) * 2020-07-17 2022-01-20 Guerbet Procede de preparation d'un ligand chelateur derive de pcta
WO2024046832A1 (de) 2022-08-30 2024-03-07 Bayer Aktiengesellschaft Erzeugen von synthetischen radiologischen aufnahmen
WO2024046833A1 (de) 2022-08-30 2024-03-07 Bayer Aktiengesellschaft Erzeugen von synthetischen radiologischen aufnahmen
WO2024046831A1 (de) 2022-08-30 2024-03-07 Bayer Aktiengesellschaft Erzeugen von synthetischen radiologischen aufnahmen
WO2024049087A1 (ko) * 2022-09-01 2024-03-07 주식회사 테라노큐어 신규한 화합물 및 이를 포함하는 mri 조영제
WO2024052156A1 (de) 2022-09-05 2024-03-14 Bayer Aktiengesellschaft Erzeugen von künstlichen kontrastverstärkten radiologischen aufnahmen
WO2024083466A1 (de) 2022-10-17 2024-04-25 Bayer Aktiengesellschaft Automatisches analysieren von radiologischen aufnahmen
EP4369353A1 (de) 2022-11-12 2024-05-15 Bayer Aktiengesellschaft Erzeugung von künstlichen kontrastmittelverstärkten radiologischen aufnahmen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0992245A1 (en) 1998-09-16 2000-04-12 Goldham Bioglan Pharma GmbH Radio-contrast agents
FR2794744B1 (fr) * 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
FR2836916B1 (fr) 2002-03-05 2004-06-11 Guerbet Sa Oligomeres de chelates de gadolinium, leur application comme produits de contraste en imagerie par resonance magnetique et leurs intermediaires de synthese
FR2883562B1 (fr) 2005-03-24 2009-02-27 Guerbet Sa Chelates lipophiles et leur utilisation en imagerie
FR2891830B1 (fr) * 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
DK2988756T4 (da) 2013-04-26 2022-08-08 Guerbet Sa Formulering af kontraststof og dertil knyttet fremstillingsfremgangsmåde
DK3770160T3 (da) * 2018-08-06 2023-02-20 Bracco Imaging Spa Kontrastmidler baseret på gadolinium-indeholdende pcta
FR3091873B1 (fr) 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification

Also Published As

Publication number Publication date
US20210196840A1 (en) 2021-07-01
CN112533921A (zh) 2021-03-19
US12036289B2 (en) 2024-07-16
PT3770160T (pt) 2023-02-21
AU2019319599B2 (en) 2024-01-04
US20200376145A1 (en) 2020-12-03
FI3770160T3 (fi) 2023-03-16
AU2019319599A1 (en) 2021-01-28
PL3687994T3 (pl) 2021-05-04
BR112021001102B1 (pt) 2022-12-20
CA3105610C (en) 2024-05-28
JP2021533165A (ja) 2021-12-02
US10973934B2 (en) 2021-04-13
EP3687994B1 (en) 2020-11-04
EP3687994A1 (en) 2020-08-05
DK3770160T3 (da) 2023-02-20
EP4151637A1 (en) 2023-03-22
CA3105610A1 (en) 2020-02-13
BR112021001102A2 (pt) 2021-04-20
WO2020030618A1 (en) 2020-02-13
EP3770160B1 (en) 2022-11-23
DK3687994T3 (da) 2021-01-25
ES2841070T3 (es) 2021-07-07
KR20210041566A (ko) 2021-04-15
EP3770160A1 (en) 2021-01-27
ES2938015T3 (es) 2023-04-03
PL3770160T3 (pl) 2023-05-29

Similar Documents

Publication Publication Date Title
PL3770160T3 (pl) Środki kontrastowe na bazie PCTA zawierające gadolin
IL272643A (en) Binders
GB201814169D0 (en) Blockchain autonoumous agents
FI3753929T3 (fi) Dimeerisiä varjoaineita
GB201706179D0 (en) Bearing arrangement
IL268288A (en) Binders
GB201707342D0 (en) Imaging agents and methods
GB201710949D0 (en) Magnetic Bearing
IL265680B (en) Dimeric contrast agents
IL277749A (en) Palladianolide compounds and their use
GB201913756D0 (en) Contrast agent
GB2546989B (en) Bearing arrangements
GB201801102D0 (en) New compounds and uses
GB201714777D0 (en) Agent
SG11202012965YA (en) External-use composition
GB201806349D0 (en) New compounds and uses
GB201705679D0 (en) Imaging agent
PT3357849T (pt) Suporte de fixação e sua utilização
ZA202102200B (en) Center bearing
ZA202103578B (en) Dna-cutting agent
ZA202103582B (en) Dna-cutting agent
EP3640406C0 (de) Lagervorrichtung
GB201820829D0 (en) Anti-mycobacterial agents
ZAF201801915S (en) Fixed bearing insert
GB201905061D0 (en) Bearing arrangement